Clinical trials were front and center in 2020, as pharma companies raced to develop and prove the safety and efficacy of their COVID-19 vaccines. Despite this increased awareness, many potential participants and referring clinicians remain unaware of available trials and how to become involved. This negatively impacts enrollment efficiency and overall study timelines.
Enter patient referral platforms. The growth of these third-party services has helped bridge the knowledge gap for both
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Curebase, AppliedVR Partner on Multiple VR Therapy Clinical Trials
What You Should Know:
- Curebase, a company committed to democratizing access to clinical studies, and AppliedVR, a pioneer advancing the next generation of digital medicine, today announced a one-year partnership where AppliedVR will deploy the Curebase platform to run five clinical trials assessing the effectiveness of virtual reality-based (VR) therapy to treat chronic pain.
- AppliedVR is the most evidence-based therapeutic VR platform for pain management and has been used by
Read More
ConcertAI, Janssen Partner to Address Health Disparities in Clinical Trials
What You Should Know:
- ConcertAI, a leader in RWD and enterprise AI tech for oncology, announced the expansion of its multi-year collaboration with Janssen. The expanded collaboration aims to further the novel work that the two companies’ are doing to broaden access to trials in new sites and strengthen trial diversity.
- This expanded collaboration, which combines ConcertAI’s broad data sets with the expertise of Janssen’s data science team, aims to advance innovative insights that
Read More
Verily Acquires Clinical Trials Management Platform SignalPath, Marks First Acquisition
What You Should Know:
Verily, an Alphabet company announced an agreement to acquire SignalPath, a Raleigh, NC-based clinical trial management system (CTMS) that improves the ease, quality and efficiency of conducting clinical research at study sites. Financial details of the acquisition were not disclosed.
- The acquisition marks Verily’s first major acquisition that will strengthen and expand Verily’s existing clinical trial system and evidence generation platform, known as Baseline. The
Read More
Reify Health Secures $220M to Go Beyond Decentralized Clinical Trials
What You Should Know:
- Reify Health, a Boston-based company paving the way to faster, predictable, and more accessible clinical trials, today announced it has raised $220M in a Series C funding round led by Coatue Management, joined by ICONIQ Growth and Adams Street Partners, as well as existing investors Sierra Ventures and Battery Ventures. This latest funding brings the company’s valuation to $2.2B.
- Reify Health has built a new foundation for how clinical trials are run through its
Read More
4G Clinical Secures $230M for Randomization and Trial Supply Management
What You Should Know:
- 4G Clinical, a cutting-edge randomization and trial supply management (RTSM) company, today announced it has entered into an agreement to receive a growth equity investment of over $230MM from Goldman Sachs Asset Management ("Goldman Sachs").
- Founded in 2015, 4G Clinical's Prancer RTSMⓇ enables life sciences companies to reach First Patient In (FPI) up to 50% faster than other providers and implement mid-study changes more efficiently. 4G Clinical's clinical
Read More
Medable Launches Decentralized Clinical Trials Enablement Program
What You Should Know:
- Medable Inc., a software platform for patient-centered drug development, today announced an industry-first digital certification program that provides life sciences companies with specialized tools, knowledge sharing and skills development to rapidly scale their decentralized and hybrid trial strategies.
- Hybrid/decentralized clinical trials have unleashed an entirely new patient experience, but this new approach to clinical research will only work if
Read More
Lightship Partners with Castor to Scale Virtual Clinical Trials Worldwide
- Lightship and Castor, providers of decentralized clinical trial solutions, today announced a strategic partnership to run direct-to-patient (hybrid) clinical trials at scale. The partnership combines operational excellence in clinical studies and technology that delivers for the most complex clinical trials.
- Lightship’s end-to-end delivery model combined with an in-house care team provide the best possible patient experience in clinical trials.
- By partnering with Castor’s
Read More
Medidata Announces Decentralized Clinical Trials Program
What You Should Know:
- Today Medidata, a Dassault Systèmes company, announced the launch of the Medidata Decentralized Clinical Trials (DCT) Program, the most comprehensive set of unified, secure technologies that enable full decentralization across the clinical trial continuum.
For the first time ever, drug, vaccine, and medical device developers (sponsors) and contract research organizations (CROs) can take advantage of the only platform offering on the market which combines:
-
Read More
Hawthorne Effect Secures $20M to Decentralize Clinical Trials
What You Should Know:
- Hawthorne Effect, a San Francisco-based solution for decentralizing clinical trials, today announced it has raised $20M in Series A funding led by Northpond Ventures with participation from SignalFire and P5 Health Ventures.
- Founded in 2015, Hawthrone Effect alleviates key issues related to patient recruitment and retention via its tech-driven platform and expansive network of medical professionals.
Hawthrone’s key offerings include:
- Hawthorne Cloud: The
Read More
